Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

3.50
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
3.25
Today|||52-Week Range
5.33
-4.89%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close3.50
Today’s open3.40
Day’s range3.34 - 3.59
Volume378,098
Average volume (3 months)187,434
Market cap$74.2M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+6.31%
Earnings growth (this year)+3.85%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
NNVCNanoViricides Inc0.000.00%
CEMIChembio Diagnostics ...0.000.00%
AGTCApplied Genetic Tech...0.000.00%
MRNSMarinus Pharmaceutic...0.000.00%
Data as of 6:30pm ET, 12/15/2017

Financials

Next reporting dateMarch 6, 2018
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$19.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Secretary, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts